Inventor
ALTENBACH ROBERT J
US45 patents
⚠️ This page may combine multiple inventors who share the name “ALTENBACH ROBERT J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
20 patentsUS7153889B2Dec 26, 2006
Bicyclic-substituted amines as histamine-3 receptor ligands
ABBOTT LAB18 citations92
US7094790B2Aug 22, 2006
Fused bicyclic-substituted amines as histamine-3 receptor ligands
ABBOTT LAB19 citations92
US6538004B2Mar 25, 2003
Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
ABBOTT LAB25 citations92
US5891882AApr 6, 1999
Benzopyranopyrrole and benzopyranopyridine α-1 adenergic compounds
ABBOTT LAB29 citations92
US5792767AAug 11, 1998
Bicyclic substituted hexahydrobenz e! isoindole alpha-1 adrenergic antagonists
ABBOTT LAB37 citations92
US5597823AJan 28, 1997
Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists
ABBOTT LAB31 citations92
US7098222B2Aug 29, 2006
Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
ABBOTT LAB20 citations83
US7205316B2Apr 17, 2007
Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
ABBOTT LAB7 citations74
US5521181AMay 28, 1996
Bicyclic substituted hexahydrobenz[e]isoindole α-1 adrenergic antagonists
ABBOTT LAB15 citations72
US7456196B2Nov 25, 2008
Bicyclic-substituted amines as histamine-3 receptor ligands
ABBOTT LAB1 citations63
US6780872B2Aug 24, 2004
Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
ABBOTT LAB3 citations63
US7807697B2Oct 5, 2010
Fused bicyclic-substituted amines as histamine-3 receptor ligands
ABBOTT LAB2 citations62
US6503935B1Jan 7, 2003
Imidazoles and related compounds as α1A agonists
ABBOTT LAB5 citations62
US5180733AJan 19, 1993
Biogenic amine uptake inhibitors
ABBOTT LAB4 citations62
US6645968B2Nov 11, 2003
Potassium channel openers
ABBOTT LAB5 citations61
US6191140B1Feb 20, 2001
Pyrano, piperidino, and thiopyrano compounds and methods of use
ABBOTT LAB3 citations60
US5248677ASep 28, 1993
Biogentic amine uptake inhibitors
ABBOTT LAB1 citations52
US6632418B2Oct 14, 2003
Radioligands and their use for identifying potassium channel modulators
ABBOTT LAB0 citations42
US6642222B2Nov 4, 2003
Pyrano, piperidino, and thiopyrano compounds and methods of use
ABBOTT LAB0 citations39
US7985745B2Jul 26, 2011
Method for pain treatment
ABBOTT LAB0 citations37
ABBVIE SARL
6 patentsUS10118916B2Nov 6, 2018
Modulators of cystic fibrosis transmembrane conductance regulator protein
ABBVIE SARL30 citations93
US10138227B2Nov 27, 2018
Heteroaryl substituted pyridines and methods of use
ABBVIE SARL31 citations92
US9981910B2May 29, 2018
Substituted pyrrolidines and methods of use
ABBVIE SARL31 citations92
US10399940B2Sep 3, 2019
Substituted pyrrolidines and methods of use
ABBVIE SARL4 citations71
US10604515B2Mar 31, 2020
Heteroaryl substituted pyridines and methods of use
ABBVIE SARL1 citations61
US10428017B2Oct 1, 2019
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE SARL1 citations61
ABBVIE OVERSEAS SARL
5 patentsUS10988454B2Apr 27, 2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL1 citations70
US10981890B2Apr 20, 2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations59
US10844042B2Nov 24, 2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations49
US10844041B2Nov 24, 2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations49
US10829473B2Nov 10, 2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations49